#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Prostate cancer Obesity Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Non-small cell lung cancer metastatic Malignant melanoma Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Rett syndrome Amyotrophic lateral sclerosis gene carrier Exudative retinopathy Cardiac sarcoidosis Myeloid leukaemia Primary amyloidosis Hidradenitis Fusarium infection Encephalitis autoimmune Thromboangiitis obliterans Oesophageal squamous cell carcinoma stage II Dupuytren's contracture Transitional cell carcinoma Peritoneal neoplasm Osteochondrodysplasia More trials…

    Learn about Rare Diseases

    Bronchiolitis obliterans syndrome – Basic Information Nephroblastoma – Diagnostics Prader-Willi syndrome – Treatment Mucopolysaccharidosis Sarcoma – Life with Disease Ewing’s sarcoma metastatic – Life with Disease Hereditary neuropathic amyloidosis – Life with Disease Primary biliary cholangitis – Basic Information Synovial sarcoma recurrent – Life with Disease Activated PI3 kinase delta syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Talquetamab Tamoxifen Clobetasol Glepaglutide Cefuroxime Human Serum Albumin 5% Anb032 Carbetocin Omeprazole Bexotegrast Mosaic Hbcoreag Amsacrine Polatuzumab Vedotin ULTEVURSEN CICLOPIROX Tetracaine Hydrochloride Mepacrine Regn7257 YOHIMBINE HYDROCHLORIDE Amb-05X More therapies…

    Learn about Your Condition

    Oesophageal atresia Marfan's syndrome Hepatitis D Colon cancer stage IV Chorioretinitis Immune-mediated renal disorder Lymphangioleiomyomatosis Trisomy 21 Ophthalmoplegia Haemorrhage Short-bowel syndrome Metastatic gastric cancer Progressive multiple sclerosis Skin papilloma Medulloblastoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Bucharest

  • A study to evaluate the effect of orforglipron on cardiovascular health in adults with atherosclerotic cardiovascular disease and/or chronic kidney disease

    Recruiting

    3 1
    Investigated Diseases:
    • Arteriosclerosis
    • Chronic kidney disease
    Austria Belgium Bulgaria Czechia Estonia France +10
  • Study on Clazakizumab for Heart Disease in Adults with End-Stage Kidney Disease on Dialysis

    Recruiting

    4 1
    Investigated Drugs:
    • Clazakizumab
    Austria Belgium Bulgaria Croatia Czechia Denmark +16
  • Long‑Term Safety, Tolerability and Efficacy of Azetukalner in Patients with Major Depressive Disorder

    Recruiting

    3 1 1
    Investigated Diseases:
    • Major depression
    Investigated Drugs:
    • Azetukalner
    Finland Germany Poland Romania Slovakia Spain
  • A study to evaluate the efficacy and safety of depemokimab and salbutamol sulfate in patients with chronic obstructive pulmonary disease and type 2 inflammation.

    Recruiting

    3 1 1
    Investigated Drugs:
    • Salbutamol Sulfate
    • Depemokimab
    Belgium Bulgaria Denmark France Germany Greece +6
  • Phase 1/2 Study of CR-001 Safety and Dose Finding in Adults with Locally Advanced or Metastatic Solid Tumors

    Recruiting

    2 1 1
    France Ireland Italy Romania Spain
  • Zenagamtide Compared with Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes

    Recruiting

    3 1 1
    Investigated Diseases:
    • Obesity
    • Overweight
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Semaglutide
    Bulgaria Croatia Germany Hungary Poland Portugal +1
1 2 3 … 101
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Pembrolizumab Carboplatin Cisplatin Paclitaxel Pemetrexed Nivolumab Rituximab Fluorouracil Dexamethasone Oxaliplatin Prednisolone Capecitabine Trospium Chloride Docetaxel Xanomeline Tartrate Gemcitabine Paclitaxel Albumin-Bound Cyclophosphamide Paracetamol Sodium Chloride Bevacizumab Lenalidomide Tocilizumab Etoposide Durvalumab Cytarabine Doxorubicin Hydrochloride Tenofovir Disoproxil Pemetrexed Disodium Ianalumab Show more

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

Acquired antithrombin III deficiency Acromegaly Acute cardiac event Acute coronary syndrome Acute lymphocytic leukaemia Acute lymphocytic leukaemia recurrent Acute myeloid leukaemia Acute myocardial infarction Acute promyelocytic leukaemia Acute respiratory distress syndrome Acute respiratory failure Adenocarcinoma gastric Adenocarcinoma pancreas Adrenogenital syndrome Alcohol use disorder Alopecia areata Alveolar proteinosis Anaemia of chronic disease Angina pectoris Anhedonia Anti-neutrophil cytoplasmic antibody positive vasculitis Arteriosclerosis Arteriovenous graft thrombosis Asthma Atrial fibrillation Autism spectrum disorder Axial spondyloarthritis B-cell lymphoma B-cell small lymphocytic lymphoma Bacterial vaginosis Bipolar disorder Bipolar I disorder Bladder cancer Bladder cancer stage 0 with cancer in situ Bladder cancer stage I with cancer in situ Bladder transitional cell carcinoma stage IV Breast cancer Breast cancer female Breast cancer metastatic Bronchiectasis Carcinoid syndrome Cardiac failure Cardiac failure chronic Cardiomyopathy Cardiovascular disorder Cerebrovascular accident prophylaxis Cervix carcinoma Cholangiocarcinoma Chronic cutaneous lupus erythematosus Chronic hepatitis Chronic hepatitis B Chronic hepatitis C Chronic inflammatory demyelinating polyradiculoneuropathy Chronic kidney disease Chronic lymphocytic leukaemia Chronic lymphocytic leukaemia recurrent Chronic myeloid leukaemia Chronic myelomonocytic leukaemia Chronic obstructive pulmonary disease Chronic rhinosinusitis with nasal polyps Clear cell renal cell carcinoma Clostridium difficile infection Coagulation factor X level Coeliac disease Cold urticaria Colitis ulcerative Colorectal adenocarcinoma Colorectal cancer Colorectal cancer metastatic Colorectal cancer stage IV Conjunctivitis allergic Connective tissue disorder Contraception COVID-19 Crohn's disease Cushing's syndrome Cutaneous lupus erythematosus Dementia Alzheimer's type Dementia of the Alzheimer's type with delusions Dermatitis Dermatitis atopic Dermatomyositis Diabetic foot infection Diffuse large B-cell lymphoma Dilated cardiomyopathy Dry age-related macular degeneration Dry eye Duchenne muscular dystrophy Dyslipidaemia EGFR gene mutation Embolism Endocrine ophthalmopathy Endometrial cancer Endometriosis Epilepsy Epstein-Barr virus associated lymphoma Erosive oesophagitis Essential thrombocythaemia Fabry's disease Factor IX deficiency Factor VIII deficiency Fallopian tube cancer Focal segmental glomerulosclerosis Follicle centre lymphoma follicular grade I, II - III Follicular lymphoma Gastric cancer Gastric cancer recurrent Gastroenteropancreatic neuroendocrine tumour disease Gastrointestinal cancer metastatic Gastrooesophageal cancer Gastrooesophageal reflux disease Gingival bleeding Glioma Growth hormone deficiency Haemolytic uraemic syndrome Haemophilia Haemorrhage prophylaxis Head and neck cancer Heparin resistance Hepatic cirrhosis Hepatitis B Hepatitis D Hepatobiliary cancer Hepatocellular carcinoma HER2 mutant non-small cell lung cancer HER2 positive breast cancer HER2 positive gastric cancer Hereditary haemochromatosis Hidradenitis High-grade B-cell lymphoma HIV infection Hormone receptor positive breast cancer Hormone receptor positive HER2 negative breast cancer Hormone-refractory prostate cancer Human epidermal growth factor receptor negative Human papilloma virus test Hyperadrenocorticism Hypereosinophilic syndrome Hyperkalaemia Hypertension Hypertriglyceridaemia Hypoparathyroidism Hypophosphatasia Idiopathic pulmonary fibrosis Immune thrombocytopenia Influenza Iron deficiency Ischaemic stroke Juvenile absence epilepsy K-ras gene mutation Lennox-Gastaut syndrome Lipoprotein metabolism disorder Lung neoplasm malignant Lupus nephritis Major depression Malignant lymphoid neoplasm Malignant melanoma Malignant melanoma stage II Malignant melanoma stage III Malignant melanoma stage IV Mania Mantle cell lymphoma Marginal zone lymphoma Medullary thyroid cancer Meningococcal infection Metabolic dysfunction-associated liver disease Metabolic dysfunction-associated steatohepatitis Metastatic gastric cancer Metastatic malignant melanoma Microsatellite instability cancer Migraine Migraine with aura Migraine without aura Multiple sclerosis Myasthenia gravis Myelodysplastic syndrome Myelofibrosis Myocardial ischaemia Neoplasm Neoplasm malignant Neurogenic bladder Non-alcoholic steatohepatitis Non-Hodgkin's lymphoma Non-Hodgkin's lymphoma unspecified histology aggressive recurrent Non-small cell lung cancer Non-small cell lung cancer metastatic Non-small cell lung cancer recurrent Non-small cell lung cancer stage II Non-small cell lung cancer stage III Non-small cell lung cancer stage IIIA Non-small cell lung cancer stage IIIB Non-small cell lung cancer stage IV Obesity Oesophageal adenocarcinoma Oesophageal adenocarcinoma stage II Oesophageal adenocarcinoma stage III Oesophageal cancer metastatic Oesophageal carcinoma Oesophageal squamous cell carcinoma Oesophageal squamous cell carcinoma stage II Oesophageal squamous cell carcinoma stage III Osteoarthritis Osteochondrodysplasia Ovarian cancer Ovarian cancer metastatic Ovarian cancer recurrent Ovarian cancer stage III Ovarian cancer stage IV Ovarian epithelial cancer recurrent Overweight Pancreatic carcinoma metastatic Papilloma viral infection Paroxysmal nocturnal haemoglobinuria Partial seizures Petit mal epilepsy Philadelphia positive acute lymphocytic leukaemia Pituitary-dependent Cushing's syndrome Plasma cell myeloma Plasma cell myeloma refractory Platelet aggregation Platelet aggregation inhibition Platelet aggregation test Pneumonia Prader-Willi syndrome Primary biliary cholangitis Primary myelofibrosis Primary progressive multiple sclerosis Progressive relapsing multiple sclerosis Prophylaxis of nausea and vomiting Prostate cancer Prostate cancer metastatic Psoriasis Psoriatic arthropathy Psychotic disorder Pulmonary arterial hypertension Pulmonary hypertension Pulmonary tuberculosis Relapsing multiple sclerosis Relapsing-remitting multiple sclerosis Renal cancer stage IV Renal cell carcinoma Renal disorder Respiratory syncytial virus infection Rheumatoid arthritis Schizophrenia Secondary immunodeficiency Secondary progressive multiple sclerosis Short stature Sjogren's syndrome Skin neoplasm excision Skin squamous cell carcinoma metastatic Skin squamous cell carcinoma recurrent Small cell lung cancer Small cell lung cancer extensive stage Small cell lung cancer limited stage Small cell lung cancer metastatic Squamous cell carcinoma Squamous cell carcinoma of head and neck Squamous cell carcinoma of lung Squamous cell carcinoma of skin Stress Subacute cutaneous lupus erythematosus Systemic lupus erythematosus Systemic scleroderma Thrombocytopenia Thrombocytosis Thrombosis prophylaxis Tourette's disorder Transitional cell cancer of the renal pelvis and ureter Transitional cell carcinoma Triple negative breast cancer Type 1 diabetes mellitus Type 2 diabetes mellitus Urinary incontinence Urinary tract infection Urticaria cholinergic Urticaria chronic Vomiting Vulvovaginal candidiasis Warm autoimmune haemolytic anaemia Weight control

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!